Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- MBIO
- Price
- 1.07
- Stock movement up
- +0.07 (7.00%)
- Company name
- Mustang Bio Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 6.91M
- Ent value
- -2.49M
- Price/Sales
- 3.47
- Price/Book
- 0.71
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -69.44%
- 1 year return (CAGR)
- -75.29%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
MBIO does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.47 |
| Price to Book | 0.71 |
| EV to Sales | -1.25 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 6.45M |
| EPS (TTM) | -0.37 |
| FCF per share (TTM) | -0.89 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.99M |
| Gross profit (TTM) | 955.00K |
| Operating income (TTM) | -2.78M |
| Net income (TTM) | -2.33M |
| EPS (TTM) | -0.37 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 47.94% |
| Operating margin (TTM) | -139.51% |
| Profit margin (TTM) | -117.22% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 18.98M |
| Net receivables | 217.00K |
| Total current assets | 19.36M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 19.36M |
| Accounts payable | 4.99M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 9.44M |
| Total liabilities | 9.59M |
| Shareholder's equity | 9.77M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.54M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -5.54M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -23.90% |
| Return on Assets | -12.06% |
| Return on Invested Capital | -23.90% |
| Cash Return on Invested Capital | -56.73% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.05 |
| Daily high | 1.09 |
| Daily low | 1.04 |
| Daily Volume | 72K |
| All-time high | 9825.00 |
| 1y analyst estimate | 10.00 |
| Beta | 2.09 |
| EPS (TTM) | -0.37 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MBIO | S&P500 | |
| Current price drop from All-time high | -99.99% | -0.89% |
| Highest price drop | -99.99% | -19.00% |
| Date of highest drop | 30 Dec 2025 | 8 Apr 2025 |
| Avg drop from high | -99.96% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
6.91M
Marketcap category
Small-cap
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Employees
6
Website
Investor relations
-
SEC filings
CEO
Manuel Litchman
Country
USA
City
Worcester
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page